公告日期：2024-08-24

Joincare Pharmaceutical Group Industry Co., Ltd. Interim Report 2024

Joincare Pharmaceutical Group Industry Co., Ltd. Interim Report 2024

Important Notice

Ⅰ The Board of Directors (the “Board”), the Board of Supervisors and directors,
supervisors and senior management of the Company hereby warrant the truthfulness,
accuracy and completeness of the contents of the interim report (the “Report”), and that
there are no false representations, misleading statements or material omissions contained
in the Report, and severally and jointly accept responsibility.

Ⅱ All the directors of the Company attended the Board meeting.

Ⅲ The interim report of the Company is unaudited.

Ⅳ Mr. Zhu Baoguo (朱保国), the person-in-charge of the Company, Mr. Qiu Qingfeng
(邱庆丰), the person-in-charge of the Company's accounting work, and Ms. Guo Chenlu
(郭琛璐), the person-in-charge of the accounting department (the head of the accounting
department), declare that they hereby warrant the truthfulness, accuracy and
completeness of the financial statements contained in the Report.

Ⅴ Profit distribution plan or plan for conversion of capital reserve to share capital
approved by the Board during the Reporting Period

Not applicable

VI Risk declaration for the forward-looking statements

√Applicable □N/A

The Report contains forward-looking statements which involve the future plans, development
strategies, etc. of the Company, yet do not constitute substantive undertakings of the Company to
investors. Investors should exercise caution prior to making investment decisions.

VII Whether there is non-operating use of funds by the controlling shareholder and their
related parties
No
VIIIWhetherthereisaviolationoftheprescribeddecision-makingprocedurestoprovideexternal guarantees
No

IX Whether more than half of directors cannot warrant the truthfulness, accuracy and
completeness of the Report disclosed by the Compan……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。